Abstract
The aim of our study was to compare the significance of risk factors for osteoporosis according to gender and menopausal state in patients with rheumatoid arthritis (RA). Bone mineral density (dual X-ray absorptiometry), cumulative glucocorticoid dose, age, disease duration, body mass index (BMI) and parameters of disease activity and bone turnover were registered in 343 postmenopausal women, 100 premenopausal women and 108 men with RA. Osteoporosis was found in a significantly higher percentage in postmenopausal women (55.7%) and in men (50.5%) in comparison with premenopausal women (18%; P < 0.001). The following risk factors for osteoporosis were found: older age, low BMI and high cumulative glucocorticoid dose in postmenopausal women, low BMI and high cumulative glucocorticoid dose in men and low BMI in premenopausal women. There is a very high prevalence of osteoporosis not only in postmenopausal women but also in men with RA. Osteoporosis risk factors are strongly dependent from gender and menopausal state.
Similar content being viewed by others
References
Deodhar AA, Woolf AD (1996) Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 35:309–322
Gough AK, Lilley J, Eyre S, Holder RL, Emery P (1994) Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344:23–27
Hooyman JR, Melton LJ, Nelson AM, O’Fallon WM, Riggs BL (1984) Fractures after rheumatoid arthritis: a population based study. Arthritis Rheum 27:1353–1361
Michel BA, Bloch DA, Fries JF (1991) Predictors of fractures in early rheumatoid arthritis. J Rheumatol 18:804–808
Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK (2000) Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 43:522–530
Shenstone BD, Mahmoud A, Woodward R, Elvins D, Palmer R, Ring F, Bhalla AK (1994) Bone mineral density in nonsteroid treated early rheumatoid arthritis. Ann Rheum Dis 53:681–684
Kalla AA, Bewerunge L, Langley A, Meyers OL, Fataar AB (2002) Trabecular bone density in premenopausal rheumatoid arthritis patients. S Afr Med J 92:62–68
Tourinho TF, Stein A, Castro JA, Brenol JC (2005) Rheumatoid arthritis: evidence for bone loss in premenopausal women. J Rheumatol 32:1020–1025
Tengstrand B, Hafstrom I (2002) Bone mineral density im men is associated with erosive disease and sulfasalzine treatment but not with sex hormones. J Rheumatol 29:2299–2305
Mateo l, Nolla JM, Bonnin MR, Navarro MA, Roig-Escofet D (1995) Sex hormone status and bone mineral density in men with rheumatoid arthritis. J Rheumatol 22:1455–1460
Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK (2000) Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register. Arthritis Rheum 43:2776–2784
Nolla JM, Roig-Vilaseca D, Gomez-Vaquero C, Meteo L, Juanola X, Rodriguez-Moreno J Narvaez J, Valverde J (2006) Frequency of osteoporosis in 187 men with rheumatoid arthritis followed in a university hospital. J Rheumatol 33:1472–1475
Lodder MC, de Jong Z, Kostense PJ, Molenaar ET, Staal K, Voskuyl AE, Hazes JM, Dijkmans BA, Lems WF (2004) Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis 63:1576–1580
Haugeberg G, Orstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK (2003) Comparison of ultrasound and X-ray absorptiometry bone measurements in a case control study of female rheumatoid arthritis patients and randomly selected subjects in the population. Osteoporos Int 14:312–319
Lodder MC, Haugeberg G, Lems WF, Uhlig T, Orstavik RE, Kostense PJ, Dijkmans BA, Kvien TK, Woolf AD (2003) Oslo-Truro-Amsterdam (OSTRA) Collaborative Study. Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study. Arthritis Rheum 49:209–215
Haugeberg G, Orstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK (2002) Clinical decision rules in rheumatoid arthritis: do they identify patients at high risk for osteoporosis? Testing clinical criteria in a population based cohort of patients with rheumatoid arthritis recruited from the Oslo Rheumatoid Arthritis Register. Ann Rheum Dis 61:1085–1089
Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del Puente A, Di Munno O Frediani B, Cantatore F, Pellerito R, Bartolone S, La Montagna G, Adami S (2000) A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on bone mass in rheumatoid arthritis. J Rheumatol 27:2582–2589
Nolla JM, Fiter J, Gomez-Vaquero C, Alegre JJ, Valverde J, Roig-Escofet D (2001) Value of clinical factors in selecting postmenopausal women with rheumatoid arthritis for bone densitometry. Ann Rheum Dis 60:799–801
Shibuya K, Hagino H, Morio Y, Teshima R (2002) Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis. Clin Rheumatol 21:150–158
Noorwali AA (2004) Bone density in rheumatoid arthritis. Saudi Med J 25:766–769
Martin JC, Munro R, Campbell MK, Reid DM (1997) Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol 36:43–49
Lane NE, Pressman AR, Star VL, Cummings SR, Nevitt MC (1995) Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 10:257–263
Miyamoto S, Kageyama Y, Ozeki T, Hiyoshi M, Suzuki M, Inoue T (1999) Effects of glucocorticoids on bone mineral density in rheumatoid arthritis patients. A longitudinal study. Arch Orthop Trauma Surg 119:18–21
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Friess JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Einspruch EL (eds) (2005) An introductory guide to SPSS for windows. Sage Publications Inc., Thousand Oaks
Saario R, Sonninen P, Mottonen T, Viikari J, Toivanen A (1999) Bone mineral density of the lumbar spine in patients with advanced rheumatoid arthritis. Influence of functional capacity and corticosteroid use. Scand J Rheumatol 28:363–367
Scheidt-Nave C, Starker A (2005) The prevalence of osteoporosis and associated health care use in women 45 years and older in Germany. Results of the first German Telephone Health Survey 2003. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 48:1338–1347
Stafford l, Bleasel J, Giles A, Handelsman D (2000) Androgen deficiency and bone mineral density in men with rheumatoid arthritis. J Rheumatol 27:2786–2790
Fogarty P, O’Beirne B, Casey C (2005) Epidemiology of the most frequent diseases in the European a-symptomatic post-menopausal women. Is there any difference between Ireland and the rest of Europe? Maturitas 52(Suppl 1):3–6
Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ronday HK, Peeters AJ, de-Jonge-Bok JM, Breedveld FC, Dijkmans BA, Allaart CF, Lems WF (2007) Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis. Ann Rheum Dis 66:1508–1512
Warming L, Hassager C, Christiansen C (2002) Changes in bone mineral density with age in men and women: a longitudinal study. Osteoporosis Int 13:105–112
Yao WJ, Wu CH, Wang ST, Chang CJ, Chiu NT, Yu CY (2001) Differential changes in regional bone mineral density in healthy Chinese: age-related and sex-dependent. Calcif Tissue Int 68:330–336
Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S (1999) Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382–4389
Shevde NK, Bendixen AC, Dienger KM, Pike JW (2000) Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 97:7829–7834
Bord S, Ireland DC, Beavan SR, Compston JE (2003) The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 32:136–141
Cooper MS, Walker EA, Bland R, Fraser WD, Hewison M, Stewart PM (2000) Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone. Bone 27:375–381
Cooper MS (2004) Sensitivity of bone to glucocorticoids. Clin Sci 107:111–123
Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A (2006) Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 15:144–149
Prouteau S, Benhamou L, Courteix D (2006) Relationships between serum leptin and bone markers during stable weight, weight reduction and weight regain in male and female judoists. Eur J Endocrinol 154:389–395
Shapses SA, Riedt CS (2006) Bone, body weight, and weight reduction: what are the concerns? J Nutr 136:1453–1456
Rall LC, Roubenoff R (2004) Rheumatoid cachexia: metabolic abnormilities, mechanisms and interventions. Rheumatology 43:1219–1223
Oelzner P, Müller A, Deschner F, Hüller M, Abendroth K, Hein G, Stein G (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62:193–198
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oelzner, P., Schwabe, A., Lehmann, G. et al. Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis. Rheumatol Int 28, 1143–1150 (2008). https://doi.org/10.1007/s00296-008-0576-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-008-0576-x